Screening Assay Archives - AIT BioscienceAIT Bioscience


Category Archives for Screening Assay

AIT Bioscience Among Inc.’s 5000 Fastest Growing Private Companies

AIT Bioscience Named to Inc. Magazine’s 36th Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000   For the 2nd Time, AIT Bioscience appears on the Inc. 5000 list, Ranking No. 2366 with Three-Year Sales Growth of 153.16%   Indianapolis, IN August 16, 2017 – Inc. magazine today ranked AIT Bioscience NO. 2366 on its … read the full article » »

Other Categories: Biomarkers, LC-MS/MS Methods, Ligand Binding Assays (LBA), News

Tags: , , , , , ,

Comments Off on AIT Bioscience Among Inc.’s 5000 Fastest Growing Private Companies


Ready to Roll; an Efficient Screening Level Assay Process

Back in January we wrote about fit-for-purpose bioanalytical assay support and announced a new small molecule LC-MS/MS screening level assay service at AITB.  Well, we’ve put this process through its paces and have shown our ability to consistently get variability down below 35% and in many cases down below 20%.  For a go-no/go decision point … read the full article » »

Other Categories: News, Uncategorized

Tags: , , , ,

Comments Off on Ready to Roll; an Efficient Screening Level Assay Process


Bioanalytical Considerations for your Dermal Pharmaceutical Programs

Bioanalytical Considerations for your Dermal Pharmaceutical Programs Does your drug require sustained release or suffer from first pass metabolism losses?   Have you considered transdermal delivery via cream gel or patch?   How does bioanalysis differ for oral or dermal delivery?   The dermis is the largest organ of the human body and provides a … read the full article » »

Other Categories: LC-MS/MS Methods, Special Topics

Tags: , , , , ,

Comments Off on Bioanalytical Considerations for your Dermal Pharmaceutical Programs


AIT Bioscience Offers New Screening Level Assay

AIT Bioscience Offers New Screening Level Assay     A fit-for-purpose approach to bioanalytical assay support balances intended use of data with regulatory requirements and budgets. FDA regulated studies (GLP Tox or Clinical) require the use of a fully validated bioanalytical assay. However, for non-regulated studies sponsors often ask themselves, and their bioanalytical CRO partners, … read the full article » »

Other Categories: Electronic Lab Notebooks (ELN), Ligand Binding Assays (LBA)



Comments Off on AIT Bioscience Offers New Screening Level Assay